National Research (NRCIB) vs. Its Peers Critical Survey

National Research (NASDAQ: NRCIB) is one of 304 publicly-traded companies in the “BUSINESS SERVICES” industry, but how does it compare to its peers? We will compare National Research to similar companies based on the strength of its analyst recommendations, dividends, profitability, risk, institutional ownership, earnings and valuation.

Analyst Ratings

How to Become a New Pot Stock Millionaire

This is a summary of recent recommendations for National Research and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
National Research 0 0 0 0 N/A
National Research Competitors 1128 5276 7878 223 2.50

As a group, “BUSINESS SERVICES” companies have a potential upside of 11.25%. Given National Research’s peers higher probable upside, analysts clearly believe National Research has less favorable growth aspects than its peers.

Institutional and Insider Ownership

2.5% of National Research shares are owned by institutional investors. Comparatively, 57.5% of shares of all “BUSINESS SERVICES” companies are owned by institutional investors. 39.1% of National Research shares are owned by company insiders. Comparatively, 16.1% of shares of all “BUSINESS SERVICES” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Volatility & Risk

National Research has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, National Research’s peers have a beta of 1.01, indicating that their average stock price is 1% more volatile than the S&P 500.

Earnings and Valuation

This table compares National Research and its peers gross revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
National Research $117.56 million $22.94 million 96.16
National Research Competitors $3.01 billion $232.83 million 31.14

National Research’s peers have higher revenue and earnings than National Research. National Research is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Dividends

National Research pays an annual dividend of $2.40 per share and has a dividend yield of 4.8%. National Research pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. As a group, “BUSINESS SERVICES” companies pay a dividend yield of 1.6% and pay out 47.0% of their earnings in the form of a dividend.

Profitability

This table compares National Research and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
National Research 19.52% 27.45% 19.09%
National Research Competitors -158.38% -95.29% -3.28%

About National Research

National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers Market Insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides Experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. In addition, the company offers Transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction, and support safe care transitions; and Risk Assessment solutions that enables clients to segment populations and manage care for those who are most at-risk, engage individuals, enhance preventative care, and manage wellness programs. Further, it provides Transparency Solutions, which allow healthcare organizations to share a picture of their organization and ensure that content informs in consumer decision-making; and Governance Solutions, which are membership services for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, and hospice, as well as payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: Analysts Anticipate PennantPark Investment Co.  Will Post Quarterly Sales of $27.23 Million
Zacks: Analysts Anticipate PennantPark Investment Co. Will Post Quarterly Sales of $27.23 Million
RSP Permian  Given a $69.00 Price Target by Stephens Analysts
RSP Permian Given a $69.00 Price Target by Stephens Analysts
Sandler O’Neill Analysts Give Simmons First National  a $35.00 Price Target
Sandler O’Neill Analysts Give Simmons First National a $35.00 Price Target
Wells Fargo Downgrades Emergent BioSolutions  to Market Perform
Wells Fargo Downgrades Emergent BioSolutions to Market Perform
Targa Resources  PT Set at $53.00 by Seaport Global Securities
Targa Resources PT Set at $53.00 by Seaport Global Securities
Cognex  Raised to Buy at Zacks Investment Research
Cognex Raised to Buy at Zacks Investment Research


© 2006-2018 Ticker Report. Google+.